vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and GREENPOWER MOTOR Co INC. (GP). Click either name above to swap in a different company.

Baird Medical Investment Holdings Ltd is the larger business by last-quarter revenue ($8.0M vs $7.2M, roughly 1.1× GREENPOWER MOTOR Co INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -142.7%, a 77.1% gap on every dollar of revenue.

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

BDMD vs GP — Head-to-Head

Bigger by revenue
BDMD
BDMD
1.1× larger
BDMD
$8.0M
$7.2M
GP
Higher net margin
GP
GP
77.1% more per $
GP
-65.6%
-142.7%
BDMD

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
BDMD
BDMD
GP
GP
Revenue
$8.0M
$7.2M
Net Profit
$-11.4M
$-4.7M
Gross Margin
82.1%
14.6%
Operating Margin
-131.3%
Net Margin
-142.7%
-65.6%
Revenue YoY
-11.5%
Net Profit YoY
-2.1%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
GP
GP
Q2 25
$8.0M
Q4 24
$7.2M
Q3 24
$5.3M
Q2 24
$3.0M
Q4 23
$8.2M
Q3 23
$8.4M
Q2 23
$17.6M
Q4 22
$12.8M
Net Profit
BDMD
BDMD
GP
GP
Q2 25
$-11.4M
Q4 24
$-4.7M
Q3 24
$-4.7M
Q2 24
$-5.4M
Q4 23
$-4.6M
Q3 23
$-4.3M
Q2 23
$-2.8M
Q4 22
$-3.4M
Gross Margin
BDMD
BDMD
GP
GP
Q2 25
82.1%
Q4 24
14.6%
Q3 24
8.6%
Q2 24
7.4%
Q4 23
16.6%
Q3 23
14.6%
Q2 23
15.9%
Q4 22
17.4%
Operating Margin
BDMD
BDMD
GP
GP
Q2 25
-131.3%
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22
Net Margin
BDMD
BDMD
GP
GP
Q2 25
-142.7%
Q4 24
-65.6%
Q3 24
-87.9%
Q2 24
-179.8%
Q4 23
-56.9%
Q3 23
-50.4%
Q2 23
-16.0%
Q4 22
-26.4%
EPS (diluted)
BDMD
BDMD
GP
GP
Q2 25
Q4 24
$-0.17
Q3 24
$-0.18
Q2 24
$-0.21
Q4 23
$-0.19
Q3 23
$-0.17
Q2 23
$-0.11
Q4 22
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
GP
GP
Cash + ST InvestmentsLiquidity on hand
$621.1K
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$2.1M
Total Assets
$77.0M
$37.4M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
GP
GP
Q2 25
Q4 24
$621.1K
Q3 24
$116.9K
Q2 24
$528.3K
Q4 23
$4.0M
Q3 23
$2.0M
Q2 23
$1.5M
Q4 22
$609.6K
Total Debt
BDMD
BDMD
GP
GP
Q2 25
$8.4M
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22
Stockholders' Equity
BDMD
BDMD
GP
GP
Q2 25
$35.6M
Q4 24
$2.1M
Q3 24
$4.2M
Q2 24
$8.6M
Q4 23
$18.1M
Q3 23
$22.3M
Q2 23
$26.2M
Q4 22
$27.3M
Total Assets
BDMD
BDMD
GP
GP
Q2 25
$77.0M
Q4 24
$37.4M
Q3 24
$39.4M
Q2 24
$43.5M
Q4 23
$50.2M
Q3 23
Q2 23
Q4 22
Debt / Equity
BDMD
BDMD
GP
GP
Q2 25
0.24×
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
GP
GP
Operating Cash FlowLast quarter
$-3.2M
$-1.1M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-40.7%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
GP
GP
Q2 25
$-3.2M
Q4 24
$-1.1M
Q3 24
$-1.3M
Q2 24
$-3.2M
Q4 23
$1.4M
Q3 23
$-5.4M
Q2 23
$7.8M
Q4 22
Free Cash Flow
BDMD
BDMD
GP
GP
Q2 25
$-3.2M
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22
FCF Margin
BDMD
BDMD
GP
GP
Q2 25
-40.7%
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22
Capex Intensity
BDMD
BDMD
GP
GP
Q2 25
0.6%
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons